Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		139,159,534
Beginning balance at Dec. 31, 2022	$ 1,116,780	$ 14	$ 2,068,225	$ (2,316)	$ (949,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		272,032
Exercise of stock options	3,651		3,651
Stock-based compensation	47,060		47,060
Issuance of common stock upon settlement of restricted stock units (in shares)		940,122
Other comprehensive income (loss)	308			308
Net loss	(63,447)				(63,447)
Ending balance (in shares) at Mar. 31, 2023		140,371,688
Ending balance at Mar. 31, 2023	1,104,352	$ 14	2,118,936	(2,008)	(1,012,590)
Beginning balance (in shares) at Dec. 31, 2023		144,806,464
Beginning balance at Dec. 31, 2023	$ 1,155,610	$ 15	2,295,807	(1,375)	(1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	471,310	471,310
Exercise of stock options	$ 7,140		7,140
Stock-based compensation	42,590		42,590
Issuance of common stock upon settlement of restricted stock units (in shares)		994,029
Other comprehensive income (loss)	(693)			(693)
Net loss	(10,966)				(10,966)
Ending balance (in shares) at Mar. 31, 2024		146,271,803
Ending balance at Mar. 31, 2024	$ 1,193,681	$ 15	$ 2,345,537	$ (2,068)	$ (1,149,803)